2023-07-012024-06-302024-06-30false12668056ISN MEDICAL LTD2025-03-0546190falseiso4217:GBPxbrli:pure126680562023-07-01126680562024-06-30126680562023-07-012024-06-30126680562022-07-01126680562023-06-30126680562022-07-012023-06-3012668056bus:SmallEntities2023-07-012024-06-3012668056bus:AuditExempt-NoAccountantsReport2023-07-012024-06-3012668056bus:FullAccounts2023-07-012024-06-3012668056bus:PrivateLimitedCompanyLtd2023-07-012024-06-3012668056core:WithinOneYear2024-06-3012668056core:AfterOneYear2024-06-3012668056core:WithinOneYear2023-06-3012668056core:AfterOneYear2023-06-3012668056core:ShareCapital2024-06-3012668056core:SharePremium2024-06-3012668056core:RevaluationReserve2024-06-3012668056core:OtherReservesSubtotal2024-06-3012668056core:RetainedEarningsAccumulatedLosses2024-06-3012668056core:ShareCapital2023-06-3012668056core:SharePremium2023-06-3012668056core:RevaluationReserve2023-06-3012668056core:OtherReservesSubtotal2023-06-3012668056core:RetainedEarningsAccumulatedLosses2023-06-3012668056core:LandBuildings2024-06-3012668056core:PlantMachinery2024-06-3012668056core:Vehicles2024-06-3012668056core:FurnitureFittings2024-06-3012668056core:OfficeEquipment2024-06-3012668056core:NetGoodwill2024-06-3012668056core:IntangibleAssetsOtherThanGoodwill2024-06-3012668056core:ListedExchangeTraded2024-06-3012668056core:UnlistedNon-exchangeTraded2024-06-3012668056core:LandBuildings2023-06-3012668056core:PlantMachinery2023-06-3012668056core:Vehicles2023-06-3012668056core:FurnitureFittings2023-06-3012668056core:OfficeEquipment2023-06-3012668056core:NetGoodwill2023-06-3012668056core:IntangibleAssetsOtherThanGoodwill2023-06-3012668056core:ListedExchangeTraded2023-06-3012668056core:UnlistedNon-exchangeTraded2023-06-3012668056core:LandBuildings2023-07-012024-06-3012668056core:PlantMachinery2023-07-012024-06-3012668056core:Vehicles2023-07-012024-06-3012668056core:FurnitureFittings2023-07-012024-06-3012668056core:OfficeEquipment2023-07-012024-06-3012668056core:NetGoodwill2023-07-012024-06-3012668056core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3012668056core:ListedExchangeTraded2023-07-012024-06-3012668056core:UnlistedNon-exchangeTraded2023-07-012024-06-3012668056core:MoreThanFiveYears2023-07-012024-06-3012668056core:Non-currentFinancialInstruments2024-06-3012668056core:Non-currentFinancialInstruments2023-06-3012668056dpl:CostSales2023-07-012024-06-3012668056dpl:DistributionCosts2023-07-012024-06-3012668056core:LandBuildings2023-07-012024-06-3012668056core:PlantMachinery2023-07-012024-06-3012668056core:Vehicles2023-07-012024-06-3012668056core:FurnitureFittings2023-07-012024-06-3012668056core:OfficeEquipment2023-07-012024-06-3012668056dpl:AdministrativeExpenses2023-07-012024-06-3012668056core:NetGoodwill2023-07-012024-06-3012668056core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3012668056dpl:GroupUndertakings2023-07-012024-06-3012668056dpl:ParticipatingInterests2023-07-012024-06-3012668056dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-3012668056core:ListedExchangeTraded2023-07-012024-06-3012668056dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-3012668056core:UnlistedNon-exchangeTraded2023-07-012024-06-3012668056dpl:CostSales2022-07-012023-06-3012668056dpl:DistributionCosts2022-07-012023-06-3012668056core:LandBuildings2022-07-012023-06-3012668056core:PlantMachinery2022-07-012023-06-3012668056core:Vehicles2022-07-012023-06-3012668056core:FurnitureFittings2022-07-012023-06-3012668056core:OfficeEquipment2022-07-012023-06-3012668056dpl:AdministrativeExpenses2022-07-012023-06-3012668056core:NetGoodwill2022-07-012023-06-3012668056core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3012668056dpl:GroupUndertakings2022-07-012023-06-3012668056dpl:ParticipatingInterests2022-07-012023-06-3012668056dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3012668056core:ListedExchangeTraded2022-07-012023-06-3012668056dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3012668056core:UnlistedNon-exchangeTraded2022-07-012023-06-3012668056core:NetGoodwill2024-06-3012668056core:IntangibleAssetsOtherThanGoodwill2024-06-3012668056core:LandBuildings2024-06-3012668056core:PlantMachinery2024-06-3012668056core:Vehicles2024-06-3012668056core:FurnitureFittings2024-06-3012668056core:OfficeEquipment2024-06-3012668056core:AfterOneYear2024-06-3012668056core:WithinOneYear2024-06-3012668056core:ListedExchangeTraded2024-06-3012668056core:UnlistedNon-exchangeTraded2024-06-3012668056core:ShareCapital2024-06-3012668056core:SharePremium2024-06-3012668056core:RevaluationReserve2024-06-3012668056core:OtherReservesSubtotal2024-06-3012668056core:RetainedEarningsAccumulatedLosses2024-06-3012668056core:NetGoodwill2023-06-3012668056core:IntangibleAssetsOtherThanGoodwill2023-06-3012668056core:LandBuildings2023-06-3012668056core:PlantMachinery2023-06-3012668056core:Vehicles2023-06-3012668056core:FurnitureFittings2023-06-3012668056core:OfficeEquipment2023-06-3012668056core:AfterOneYear2023-06-3012668056core:WithinOneYear2023-06-3012668056core:ListedExchangeTraded2023-06-3012668056core:UnlistedNon-exchangeTraded2023-06-3012668056core:ShareCapital2023-06-3012668056core:SharePremium2023-06-3012668056core:RevaluationReserve2023-06-3012668056core:OtherReservesSubtotal2023-06-3012668056core:RetainedEarningsAccumulatedLosses2023-06-3012668056core:NetGoodwill2022-07-0112668056core:IntangibleAssetsOtherThanGoodwill2022-07-0112668056core:LandBuildings2022-07-0112668056core:PlantMachinery2022-07-0112668056core:Vehicles2022-07-0112668056core:FurnitureFittings2022-07-0112668056core:OfficeEquipment2022-07-0112668056core:AfterOneYear2022-07-0112668056core:WithinOneYear2022-07-0112668056core:ListedExchangeTraded2022-07-0112668056core:UnlistedNon-exchangeTraded2022-07-0112668056core:ShareCapital2022-07-0112668056core:SharePremium2022-07-0112668056core:RevaluationReserve2022-07-0112668056core:OtherReservesSubtotal2022-07-0112668056core:RetainedEarningsAccumulatedLosses2022-07-0112668056core:AfterOneYear2023-07-012024-06-3012668056core:WithinOneYear2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3012668056core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3012668056core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3012668056core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3012668056core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3012668056core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3012668056core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3012668056core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3012668056core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3012668056core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3012668056bus:Director12023-07-012024-06-3012668056core:FurnitureFittingsToolsEquipment2023-06-3012668056core:FurnitureFittingsToolsEquipment2024-06-3012668056core:FurnitureFittingsToolsEquipment2023-07-012024-06-30

ISN MEDICAL LTD

Registered Number
12668056
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2024

ISN MEDICAL LTD
Company Information
for the year from 1 July 2023 to 30 June 2024

Director

JENKINS, Mark Alexander

Registered Address

Whiteleaf Business Centre
11 Little Balmer
Buckingham
MK18 1TF

Registered Number

12668056 (England and Wales)
ISN MEDICAL LTD
Balance Sheet as at
30 June 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3528920
528920
Current assets
Debtors4,3894,347
Cash at bank and on hand14183
4,4034,530
Creditors amounts falling due within one year4(5,300)(5,251)
Net current assets (liabilities)(897)(721)
Total assets less current liabilities(369)199
Provisions for liabilities5(99)(174)
Net assets(468)25
Capital and reserves
Called up share capital11
Profit and loss account(469)24
Shareholders' funds(468)25
The financial statements were approved and authorised for issue by the Director on 5 March 2025, and are signed on its behalf by:
JENKINS, Mark Alexander
Director
Registered Company No. 12668056
ISN MEDICAL LTD
Notes to the Financial Statements
for the year ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Fixtures and fittings4
Office Equipment3
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Fixtures & fittings

Office Equipment

Total

£££
Cost or valuation
At 01 July 231,0174161,433
At 30 June 241,0174161,433
Depreciation and impairment
At 01 July 23339174513
Charge for year254138392
At 30 June 24593312905
Net book value
At 30 June 24424104528
At 30 June 23678242920
4.Creditors: amounts due within one year

2024

2023

££
Taxation and social security1,5501,501
Other creditors3,7503,750
Total5,3005,251
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)99174
Total99174